These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine. Lee JS; Kim HS; Seo SH Vaccine; 2008 Dec; 26(51):6569-76. PubMed ID: 18838096 [TBL] [Abstract][Full Text] [Related]
24. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines. Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454 [TBL] [Abstract][Full Text] [Related]
25. Development and characterization of a live attenuated influenza B virus vaccine candidate. Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290 [TBL] [Abstract][Full Text] [Related]
26. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. Yang P; Duan Y; Wang C; Xing L; Gao X; Tang C; Luo D; Zhao Z; Jia W; Peng D; Liu X; Wang X Vaccine; 2011 Jan; 29(4):698-705. PubMed ID: 21111782 [TBL] [Abstract][Full Text] [Related]
28. [ts-Mutations in the genomes of cold-adapted variants of influenza A/Hong Kong/1/68(H3N2) and A/Victoria/35/72(H3N2) viruses]. Zhikhareva IV; Medvedeva TE; Aleksandrova GI; Klimov AI Genetika; 1993 May; 29(5):853-61. PubMed ID: 8335243 [TBL] [Abstract][Full Text] [Related]
29. Live cold-adapted influenza A vaccine produced in Vero cell line. Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508 [TBL] [Abstract][Full Text] [Related]
30. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168 [TBL] [Abstract][Full Text] [Related]
31. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248 [TBL] [Abstract][Full Text] [Related]
32. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation. Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798 [TBL] [Abstract][Full Text] [Related]
33. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Isakova-Sivak I; Chen LM; Matsuoka Y; Voeten JT; Kiseleva I; Heldens JG; den Bosch Hv; Klimov A; Rudenko L; Cox NJ; Donis RO Virology; 2011 Apr; 412(2):297-305. PubMed ID: 21315402 [TBL] [Abstract][Full Text] [Related]
34. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219 [TBL] [Abstract][Full Text] [Related]
35. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice. Wareing MD; Watson JM; Brooks MJ; Tannock GA J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460 [TBL] [Abstract][Full Text] [Related]
36. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process. Buonagurio DA; Bechert TM; Yang CF; Shutyak L; D'Arco GA; Kazachkov Y; Wang HP; Rojas EA; O'Neill RE; Spaete RR; Coelingh KL; Zamb TJ; Sidhu MS; Udem SA Vaccine; 2006 Mar; 24(12):2151-60. PubMed ID: 16413951 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin. Lee YJ; Jang YH; Kim P; Lee YH; Lee YJ; Byun YH; Lee KH; Kim K; Seong BL Virology; 2016 Apr; 491():1-9. PubMed ID: 26874012 [TBL] [Abstract][Full Text] [Related]